Core Laboratories Inc
CLB
Market Cap$778.43M
Close$
$0.27
98.4% downside
Current Fair Value
98.4% downsideOvervalued by 98.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $778.43 Million |
|---|---|
| Enterprise Value | $802.62 Million |
| Dividend Yield | $0.04 (0.241254523522316%) |
| Earnings per Share | $0.66 |
| Beta | 2.36 |
| Outstanding Shares | 47,773,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 25.23 |
|---|---|
| PEG | 173.44 |
| Price to Sales | 1.74 |
| Price to Book Ratio | 3.48 |
| Enterprise Value to Revenue | 1.53 |
| Enterprise Value to EBIT | 14.16 |
| Enterprise Value to Net Income | 25 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.17 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Core Laboratories N.V.
4,700 employeesCore Laboratories N.V. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70 offices in more tha...